We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Tepnel Signs Quality Agreement with Pfizer for CGMP Services

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Tepnel Life Sciences PLC has announced that it’s Scottish pharmaceutical services subsidiary, Tepnel Scientific Services Ltd, has entered into a quality agreement with Pfizer.  

Under the scope of this agreement Tepnel has been selected as a supplier to Pfizer for analytical chemistry and microbiological services. 

By continuing to provide a high quality service, Tepnel expects to have the opportunity to tender for further Pfizer business.
 
Following Tepnel’s recent placing which will, in part, fund the completion of its 18,000 sq ft analytical testing facility in Scotland, Ben Matzilevich, CEO, commented, "We are delighted to announce this agreement with Pfizer which is proof of the high level of quality and regulatory compliance our systems provide."

"This agreement further strengthens Tepnel's position in the analytical outsourcing marketplace as a provider of regulatory compliant services to the pharmaceutical industry."